Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Swiss-listed BB Biotech marks 30 years of outperformance with fund manager Dr. Daniel Koller confident the recent biotechnology slump will in time look like a small setback.

BB Biotech’s Koller: This crash will look like a blip

Swiss-listed BB Biotech marks 30 years of outperformance with fund manager Dr. Daniel Koller confident the recent biotechnology slump will in time look like a small setback.
05.12.2023 - Daniel Koller

Diese Anlagestrategien könnten Sie interessieren

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-Nr.: CH0038389992YTD: 26.76%Active Share: 79.47Anzahl Positionen: 22
    Lancierungsdatum: 16. November 1993